OKYO
OKYO clinical trials: OKYO Pharma Ltd
Every trial on ClinicalTrials.gov where OKYO Pharma Ltd is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
OKYO on the catalyst calendar · OKYO registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| May 2027Sponsor estimate | NCT07838506Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic...Okyo Pharma Ltd · Neuropathic Corneal Pain | OKYOLead | Phase 3 | Not yet recruiting | Locked | Locked | Locked |
| Apr 30, 2025Actual | NCT06637527The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal PainOkyo Pharma Ltd · Neuropathic Pain | OKYOLead | Phase 2 | Terminated | Locked | Locked | Locked |
| Dec 15, 2023Actual | NCT05759208The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye DiseaseOkyo Pharma Ltd · Dry Eye Disease | OKYOLead | Phase 2 | Completed | Locked | Locked | Locked |
- Primary completion May 2027Sponsor estimatePhase 3NCT07838506Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic...Okyo Pharma Ltd · Neuropathic Corneal PainNot yet recruitingOKYOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2025ActualPhase 2NCT06637527The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal PainOkyo Pharma Ltd · Neuropathic PainTerminatedOKYOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 15, 2023ActualPhase 2NCT05759208The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye DiseaseOkyo Pharma Ltd · Dry Eye DiseaseCompletedOKYOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner